Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
Six p53 wild-type cancer cell lines from infrequently p53-mutated entities (neuroblastoma, rhabdomyosarcoma, and melanoma) were continuously exposed to increasing concentrations of the murine double minute 2 inhibitor nutlin-3, resulting in the emergence of nutlin-3-resistant, p53-mutated sublines d...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 December 2011
|
| In: |
Cell death & disease
Year: 2011, Jahrgang: 2, Pages: 1-8 |
| ISSN: | 2041-4889 |
| Online-Zugang: | Verlag, Volltext: http://www.nature.com/cddis/journal/v2/n12/full/cddis2011129a.html
|
| Verfasserangaben: | M. Michaelis, F. Rothweiler, S. Barth, J. Cinatl, M. van Rikxoort, N. Löschmann, Y. Voges, R. Breitling, A. von Deimling, F. Rödel, K. Weber, B. Fehse, E. Mack, T. Stiewe, H.W. Doerr, D. Speidel and J. Cinatl |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 730328023 | ||
| 003 | DE-627 | ||
| 005 | 20250219011655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 121122s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/cddis.2011.129 |2 doi | |
| 035 | |a (DE-627)730328023 | ||
| 035 | |a (DE-576)9730328021 | ||
| 035 | |a (DE-599)GBV730328023 | ||
| 035 | |a (OCoLC)1389793616 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michaelis, Martin |d 1972- |e VerfasserIn |0 (DE-588)123434831 |0 (DE-627)082554315 |0 (DE-576)293708096 |4 aut | |
| 245 | 1 | 0 | |a Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells |c M. Michaelis, F. Rothweiler, S. Barth, J. Cinatl, M. van Rikxoort, N. Löschmann, Y. Voges, R. Breitling, A. von Deimling, F. Rödel, K. Weber, B. Fehse, E. Mack, T. Stiewe, H.W. Doerr, D. Speidel and J. Cinatl |
| 246 | 3 | 0 | |a two three |
| 264 | 1 | |c 15 December 2011 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Six p53 wild-type cancer cell lines from infrequently p53-mutated entities (neuroblastoma, rhabdomyosarcoma, and melanoma) were continuously exposed to increasing concentrations of the murine double minute 2 inhibitor nutlin-3, resulting in the emergence of nutlin-3-resistant, p53-mutated sublines displaying a multi-drug resistance phenotype. Only 2 out of 28 sublines adapted to various cytotoxic drugs harboured p53 mutations. Nutlin-3-adapted UKF-NB-3 cells (UKF-NB-3rNutlin10 μM, harbouring a G245C mutation) were also radiation resistant. Analysis of UKF-NB-3 and UKF-NB-3rNutlin10 μM cells by RNA interference experiments and lentiviral transduction of wild-type p53 into p53-mutated UKF-NB-3rNutlin10 μM cells revealed that the loss of p53 function contributes to the multi-drug resistance of UKF-NB-3rNutlin10 μM cells. Bioinformatics PANTHER pathway analysis based on microarray measurements of mRNA abundance indicated a substantial overlap in the signalling pathways differentially regulated between UKF-NB-3rNutlin10 μM and UKF-NB-3 and between UKF-NB-3 and its cisplatin-, doxorubicin-, or vincristine-resistant sublines. Repeated nutlin-3 adaptation of neuroblastoma cells resulted in sublines harbouring various p53 mutations with high frequency. A p53 wild-type single cell-derived UKF-NB-3 clone was adapted to nutlin-3 in independent experiments. Eight out of ten resulting sublines were p53-mutated harbouring six different p53 mutations. This indicates that nutlin-3 induces de novo p53 mutations not initially present in the original cell population. Therefore, nutlin-3-treated cancer patients should be carefully monitored for the emergence of p53-mutated, multi-drug-resistant cells. | ||
| 700 | 1 | |a Rothweiler, F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barth, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cinatl, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rikxoort, M. van |e VerfasserIn |4 aut | |
| 700 | 1 | |a Löschmann, N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Voges, Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Breitling, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Rödel, F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weber, Kristoffer |d 1980- |e VerfasserIn |0 (DE-588)142015326 |0 (DE-627)632869372 |0 (DE-576)327369949 |4 aut | |
| 700 | 1 | |a Fehse, Boris |e VerfasserIn |0 (DE-588)143740997 |0 (DE-627)654331529 |0 (DE-576)177297220 |4 aut | |
| 700 | 1 | |a Mack, E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stiewe, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Doerr, Hans Wilhelm |d 1945- |e VerfasserIn |0 (DE-588)1104048493 |0 (DE-627)861610385 |0 (DE-576)470806672 |4 aut | |
| 700 | 1 | |a Speidel, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cinatl, J. Jr. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell death & disease |d London [u.a.] : Nature Publishing Group, 2010 |g 2(2011), Artikel-ID e243, Seite 1-8 |h Online-Ressource |w (DE-627)620145250 |w (DE-600)2541626-1 |w (DE-576)319429059 |x 2041-4889 |7 nnas |a Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells |
| 773 | 1 | 8 | |g volume:2 |g year:2011 |g elocationid:e243 |g pages:1-8 |g extent:8 |a Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells |
| 856 | 4 | 0 | |u http://www.nature.com/cddis/journal/v2/n12/full/cddis2011129a.html |x Verlag |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20220819 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 999 | |a KXP-PPN730328023 |e 4181009483 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1038/cddis.2011.129"],"eki":["730328023"]},"title":[{"title_sort":"Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells","title":"Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells"}],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"15 December 2011"}],"name":{"displayForm":["M. Michaelis, F. Rothweiler, S. Barth, J. Cinatl, M. van Rikxoort, N. Löschmann, Y. Voges, R. Breitling, A. von Deimling, F. Rödel, K. Weber, B. Fehse, E. Mack, T. Stiewe, H.W. Doerr, D. Speidel and J. Cinatl"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Michaelis, Martin","given":"Martin","family":"Michaelis"},{"family":"Rothweiler","given":"F.","roleDisplay":"VerfasserIn","display":"Rothweiler, F.","role":"aut"},{"given":"S.","family":"Barth","role":"aut","display":"Barth, S.","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Cinatl, J.","given":"J.","family":"Cinatl"},{"given":"M. van","family":"Rikxoort","role":"aut","roleDisplay":"VerfasserIn","display":"Rikxoort, M. van"},{"given":"N.","family":"Löschmann","role":"aut","display":"Löschmann, N.","roleDisplay":"VerfasserIn"},{"family":"Voges","given":"Y.","display":"Voges, Y.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Breitling","given":"R.","roleDisplay":"VerfasserIn","display":"Breitling, R.","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Deimling, Andreas von","given":"Andreas von","family":"Deimling"},{"given":"F.","family":"Rödel","role":"aut","roleDisplay":"VerfasserIn","display":"Rödel, F."},{"roleDisplay":"VerfasserIn","display":"Weber, Kristoffer","role":"aut","family":"Weber","given":"Kristoffer"},{"given":"Boris","family":"Fehse","role":"aut","display":"Fehse, Boris","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Mack, E.","roleDisplay":"VerfasserIn","given":"E.","family":"Mack"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Stiewe, T.","given":"T.","family":"Stiewe"},{"given":"Hans Wilhelm","family":"Doerr","role":"aut","display":"Doerr, Hans Wilhelm","roleDisplay":"VerfasserIn"},{"display":"Speidel, D.","roleDisplay":"VerfasserIn","role":"aut","family":"Speidel","given":"D."},{"family":"Cinatl","given":"J. Jr.","roleDisplay":"VerfasserIn","display":"Cinatl, J. Jr.","role":"aut"}],"recId":"730328023","relHost":[{"title":[{"title_sort":"Cell death & disease","title":"Cell death & disease"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cellsCell death & disease","note":["Gesehen am 26.02.10"],"recId":"620145250","language":["eng"],"pubHistory":["1.2010 -"],"titleAlt":[{"title":"Cell death and disease"}],"part":{"volume":"2","text":"2(2011), Artikel-ID e243, Seite 1-8","extent":"8","year":"2011","pages":"1-8"},"origin":[{"publisher":"Nature Publishing Group","dateIssuedKey":"2010","dateIssuedDisp":"2010-","publisherPlace":"London [u.a.]"}],"id":{"zdb":["2541626-1"],"eki":["620145250"],"issn":["2041-4889"]},"physDesc":[{"extent":"Online-Ressource"}]}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a MICHAELISMADAPTATION1520 | ||